Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Effects of Porphyra tenera Supplementation on the Immune System: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial.

  • 2020-06-02
  • Nutrients 12(6)
    • Su-Jin Jung
    • Hui-Yeon Jang
    • Eun-Soo Jung
    • Soon-Ok Noh
    • Sang-Wook Shin
    • Ki-Chan Ha
    • Hyang-Im Baek
    • Byung-Jae Ahn
    • Tae-Hwan Oh
    • Soo-Wan Chae

Study Design

Type
Randomized Controlled Trial (RCT)
Sample size
n = 101
Population
120 healthy adults
Methods
randomized, double-blind, placebo-controlled, 2.5 g/day PTE or placebo for 8 weeks
Blinding
Double-blind
Duration
8 weeks
Funding
Unclear
  • Large Human Trial
  • Rigorous Journal

Objective

The purpose of this study was to determine if Porphyra tenera extract (PTE) has immune-enhancing effects and is safe in healthy adults.

Methods

Subjects who met the inclusion criteria (3 × 103 ≤ peripheral blood leukocyte level ≥ 8 × 103 cells/µL) were recruited for this study. Enrolled subjects (n = 120) were randomly assigned to either the PTE group (n = 60) and were given 2.5 g/day of PTE (as PTE) in capsule form or the placebo group (n = 60) and were given crystal cellulose capsules with the identical appearance, weight, and flavor as the PTE capsules for 8 weeks. Outcomes were assessed based on measuring natural killer (NK) cell activity, cytokines level, and upper respiratory infection (URI), and safety parameters were assessed at baseline and 8 weeks.

Results

Compared with baseline, NK cell activity (%) increased for all effector cell-to-target cell ratios in the PTE group after 8 weeks; however, changes were not observed in the placebo group (p < 0.10). Subgroup analysis of 101 subjects without URI showed that NK cell activity in the PTE group tended to increase for all effector cell/target cell (E:T) ratios (E:T = 12.5:1 p = 0.068; E:T = 25:1 p = 0.036; E:T = 50:1 p = 0.081) compared with the placebo group. A significant difference between the two groups was observed for the E:T = 25:1 ratio, which increased from 20.3 ± 12.0% at baseline to 23.2 ± 12.4% after 8 weeks in the PTE group (p = 0.036). A significant difference was not observed in cytokine between the two groups.

Conclusion

PTE supplementation appears to enhance immune function by improving NK cell activity without adverse effects in healthy adults.

Research Insights

    Back to top